Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Reardon
Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Phase I Study of Sunitinib and Irinotecan for Patients With Recurrent Malignant Glioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma
Journal of Clinical Neuroscience
Medicine
Surgery
Neurology
Physiology
Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
World Journal of Oncology
Cancer Research
Oncology
The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients With High-Grade Glioma
Academic Radiology
Nuclear Medicine
Radiology
Imaging
Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma
Japanese Journal of Neurosurgery
Surgery
Neurology
Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
A Pilot Study of Peptide Vaccines for VEGF Receptor 1 and 2 in Patients With Recurrent/Progressive High Grade Glioma
Oncotarget
Oncology
Antiangiogenic Therapy Using Bevacizumab in Recurrent High-Grade Glioma: Impact on Local Control and Patient Survival
Journal of Neurosurgery
Surgery
Neurology